ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with morphine in 1 studies
| Studies (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Trials (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Recent Studies (post-2010) (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 24 | 5 | 0 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, M; Elgen, K; Hagman, A; Larsson, L; Leward, S; Wolff, T | 1 |
1 trial(s) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and morphine
| Article | Year |
|---|---|
Analgesic treatment in acute myocardial infarction. A double-blind comparison of ketobemidone + the spasmolytic A29 (Ketogan) and morphine.
Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Meperidine; Middle Aged; Morphine; Myocardial Infarction; Parasympatholytics | 1988 |